mhurhangee/patent-ind-claim-en huggingface dataset:
Apparatus comprising: synthetic beads configured with a polymer functionalized to attach to a valuable material comprising mineral particles in a mixture to form at least some enriched synthetic beads having the valuable material attached thereto, and also configured to be transported through the mixture based at least partly on a characteristic of the synthetic beads; and a flotation stage having the mixture containing the valuable material, and configured to receive the synthetic beads and to provide the at least some enriched synthetic beads having the valuable material attached thereto based at least partly on the characteristic of the synthetic beads, characterized in that the beads are made of glass coated with a polysiloxanate so that the beads become hydrophobic, or the beads are made of ceramic coated with fluoroalkylsilane so as to render the beads hydrophobic, or the beads are in the form of a solid-phase body made of polydimethylsiloxane. synthetic beads configured with a polymer functionalized to attach to a valuable material comprising mineral particles in a mixture to form at least some enriched synthetic beads having the valuable material attached thereto, and also configured to be transported through the mixture based at least partly on a characteristic of the synthetic beads; and a flotation stage having the mixture containing the valuable material, and configured to receive the synthetic beads and to provide the at least some enriched synthetic beads having the valuable material attached thereto based at least partly on the characteristic of the synthetic beads, the beads are made of glass coated with a polysiloxanate so that the beads become hydrophobic, or the beads are made of ceramic coated with fluoroalkylsilane so as to render the beads hydrophobic, or the beads are in the form of a solid-phase body made of polydimethylsiloxane.
An adrenergic beta-3-receptor blocker for use as a medicament for treatment of a cancer disease, wherein the adrenergic beta-3-receptor blocker is selected from the group consisting of SR59230A and compounds having SR59230A as nucleus, and the cancer disease is selected from a group consisting of breast carcinomas, leukemia, pulmonary carcinomas, hepatocarcinomas, colon cancers, pancreatic cancers, and prostate cancers.
An aqueous bumetanide-containing liquid comprising: • 0.3-5 wt.% bumetanide; • 2-30 wt.% of a non-ionic surfactant having a HLB of more than 10; and • 65-94 wt.% water; wherein the liquid has a pH at 25°C in the range of 5-9 and wherein each of the bumetanide and the non-ionic surfactant is dissolved and/or contained in colloidal particles having a diameter of less than 50 nm. • 0.3-5 wt.% bumetanide; • 2-30 wt.% of a non-ionic surfactant having a HLB of more than 10; and • 65-94 wt.% water;
A compound defined by Chemical Formula 1 for use in treating or preventing a degenerative brain disease; wherein, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 8 are each independently H, OH, an alkyl or alcohol of 1 to 4 carbon atoms, or alkyl-O-glucose; and R 7 is one selected from the group consisting of halogen, H, OH, O-alkyl, O-alkenyl, O-alkynyl, O-alcohol, O-carboxyl, O-ether, O-sulfonic acid (-SO 3 H), O-cycloalkyl, O-heterocycloalkyl, glucose, and O-glucose. R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 8 are each independently H, OH, an alkyl or alcohol of 1 to 4 carbon atoms, or alkyl-O-glucose; and R 7 is one selected from the group consisting of halogen, H, OH, O-alkyl, O-alkenyl, O-alkynyl, O-alcohol, O-carboxyl, O-ether, O-sulfonic acid (-SO 3 H), O-cycloalkyl, O-heterocycloalkyl, glucose, and O-glucose.
A computer-implemented method for managing parallel processing on a computer system, wherein the computer system comprises one or more computers, wherein each of the computers has at least one CPU and at least one of the computers has multiple CPUs, the method comprising: determining (S301) a scheduling limit based on the number of CPUs of the computer system, wherein the scheduling limit restricts the number of worker threads available for executing tasks on the computer system, wherein a worker thread is available when the worker thread is runnable or temporarily stopped to let another thread run; executing (S303) a plurality of tasks on the computer system; determining (S305) an availability of a CPU of a computer of the computer system based on whether a load of the CPU exceeds a first threshold, wherein the CPU is determined to be unavailable and overloaded if the load of the CPU exceeds the first threshold; when the CPU is determined to be unavailable: reducing (S307) the scheduling limit in order to prevent further parallelization from being carried out on the computer system, scheduling (S309) a further task for execution on one of the CPUs according to the reduced scheduling limit, wherein the scheduling comprises limiting the worker threads available to execute tasks on the computer system, such that the quantity of worker threads available for executing tasks does not exceed the scheduling limit. determining (S301) a scheduling limit based on the number of CPUs of the computer system, wherein the scheduling limit restricts the number of worker threads available for executing tasks on the computer system, wherein a worker thread is available when the worker thread is runnable or temporarily stopped to let another thread run; executing (S303) a plurality of tasks on the computer system; determining (S305) an availability of a CPU of a computer of the computer system based on whether a load of the CPU exceeds a first threshold, wherein the CPU is determined to be unavailable and overloaded if the load of the CPU exceeds the first threshold; when the CPU is determined to be unavailable: reducing (S307) the scheduling limit in order to prevent further parallelization from being carried out on the computer system, scheduling (S309) a further task for execution on one of the CPUs according to the reduced scheduling limit, wherein the scheduling comprises limiting the worker threads available to execute tasks on the computer system, such that the quantity of worker threads available for executing tasks does not exceed the scheduling limit. reducing (S307) the scheduling limit in order to prevent further parallelization from being carried out on the computer system, scheduling (S309) a further task for execution on one of the CPUs according to the reduced scheduling limit, wherein the scheduling comprises limiting the worker threads available to execute tasks on the computer system, such that the quantity of worker threads available for executing tasks does not exceed the scheduling limit.
A fastening device , consisting of: a case unit , comprising: a wall forming a receiving space , the wall comprising a plurality of teeth protruding radially from an inner annular surface of the wall ; an upper opening communicated with the receiving space ; a lower opening opposite to the upper opening and communicated with the receiving space ; and a base plate ; a spool within the receiving space and comprising an upper ring portion and a lower ring portion ; a knob covering the case unit ; and an engaging unit within the receiving space , the engaging unit being coupled to the knob ; wherein a diameter of the upper ring portion is larger than a diameter of a virtual circle formed by tips of the teeth such that lower edges of the teeth prohibit the spool from leaving the receiving space from the upper opening . a case unit , comprising: a wall forming a receiving space , the wall comprising a plurality of teeth protruding radially from an inner annular surface of the wall ; an upper opening communicated with the receiving space ; a lower opening opposite to the upper opening and communicated with the receiving space ; and a base plate ; a wall forming a receiving space , the wall comprising a plurality of teeth protruding radially from an inner annular surface of the wall ; an upper opening communicated with the receiving space ; a lower opening opposite to the upper opening and communicated with the receiving space ; and a base plate ; a spool within the receiving space and comprising an upper ring portion and a lower ring portion ; a knob covering the case unit ; and an engaging unit within the receiving space , the engaging unit being coupled to the knob ; wherein a diameter of the upper ring portion is larger than a diameter of a virtual circle formed by tips of the teeth such that lower edges of the teeth prohibit the spool from leaving the receiving space from the upper opening .
Fuel cell stack having at least two, in particular identical, fuel cells , which are in particular configured as bipolar plates which are stacked above one another, the fuel cells being connected fluidically to one another via at least one manifold with the same cross section, in particular cut-outs with substantially the same cross section, which are part of the bipolar plates , forming the manifolds, at least one insert member being arranged in the manifold , into which at least one flow opening for at least one of the fuel cells is introduced, characterized in that at least one guide element for influencing flow is formed in and/or on the at least one insert member , in particular immediately in and/or on the at least one flow opening .
A coating composition comprising a luminophoric material, wherein the luminophoric material is a pyridine-containing ligand chosen from a terpyridine derived from a compound of the formula: and/or and wherein R 1 -R 11 are independently chosen from an alkyl, a substituted alkyl, an aryl, a substituted aryl, an inert functional group, an alkoxysilyl functional group, and an alcohol functional group, optionally any two of R 1 -R 11 vicinal to one another, R 1 /R 11 and/or R 3 /R 4 taken together may form a ring being a substituted or unsubstituted, saturated, or unsaturated cyclic structure, with the proviso that the compound comprises an alkoxysilyl functional group, an alcohol functional group, or a combination of two or more thereof, and wherein the alcohol functional group of the compound of the formula (II) is chosen from a compound of the formula -O-(CH 2 ) m -OH where m is 1-20, the alkoxysilyl functional group of the compound of the formula (III) is chosen from a functional group of the formula: -(CH 2 ) n -Si(OR 12 ) 3 , where R 12 is C p H 2p+1 , p is 1-10, and n is 1-20, the alkoxysilyl functional group of the compound of the general formula (IV) is chosen from a functional group of the formula: -O-(CH 2 ) q -NH-C(O)-NH-(CH 2 ) r -Si(OR 13 ) 3 , wherein q and r are independently 1-20, and R 13 is C p H 2p+1 where p is 1-10, and the alkoxysilyl functional group of the compound of the general formula (V) is chosen from a functional group of the formula: -O-(CH 2 ) q -O-C(O)-NH-(CH 2 ) r -Si(OR 13 ) 3 , where A 1 and A 2 are independently chosen from an oxygen atom or NH, q and r are independently 1-20, and R 13 is C p H 2p+1 where p is 1-10. wherein R 1 -R 11 are independently chosen from an alkyl, a substituted alkyl, an aryl, a substituted aryl, an inert functional group, an alkoxysilyl functional group, and an alcohol functional group, optionally any two of R 1 -R 11 vicinal to one another, R 1 /R 11 and/or R 3 /R 4 taken together may form a ring being a substituted or unsubstituted, saturated, or unsaturated cyclic structure, with the proviso that the compound comprises an alkoxysilyl functional group, an alcohol functional group, or a combination of two or more thereof, and wherein the alcohol functional group of the compound of the formula (II) is chosen from a compound of the formula -O-(CH 2 ) m -OH where m is 1-20, the alkoxysilyl functional group of the compound of the formula (III) is chosen from a functional group of the formula: -(CH 2 ) n -Si(OR 12 ) 3 , where R 12 is C p H 2p+1 , p is 1-10, and n is 1-20, the alkoxysilyl functional group of the compound of the general formula (IV) is chosen from a functional group of the formula: -O-(CH 2 ) q -NH-C(O)-NH-(CH 2 ) r -Si(OR 13 ) 3 , wherein q and r are independently 1-20, and R 13 is C p H 2p+1 where p is 1-10, and the alkoxysilyl functional group of the compound of the general formula (V) is chosen from a functional group of the formula: -O-(CH 2 ) q -O-C(O)-NH-(CH 2 ) r -Si(OR 13 ) 3 , where A 1 and A 2 are independently chosen from an oxygen atom or NH, q and r are independently 1-20, and R 13 is C p H 2p+1 where p is 1-10.
An anti-CD37 immunoconjugate for use in a method of treating a patient having cancer, the anti-CD37 immunoconjugate having the formula (A) - (L) - (M), wherein: (A) is an antibody or antigen-binding fragment thereof that specifically binds to CD37 and comprises heavy and light chain variable region CDR sequences of SEQ ID NOs: 4-6 and SEQ ID NOs: 7-9, respectively; (L) is a linker; and (M) is a maytansinoid; and wherein the linker (L) links (A) to (M); wherein an increased expression level has been detected in a cancer sample isolated from the patient for at least one gene selected from the group consisting of: SLC6A16, CD79A, BASP1, CXCR5, BIK, LY86, TLR10, CD86, LCK, CD22, PTPN22, BCL6, PIK3IP1, CDKN2A, AFF3, PIM1, MGMT, PDE4B, NFKBIE, SYK, FOXO1, CHI3L2, FAM117B, LPAR5, NFATC1, PTPN22, RBM38, and SGPP1. (A) is an antibody or antigen-binding fragment thereof that specifically binds to CD37 and comprises heavy and light chain variable region CDR sequences of SEQ ID NOs: 4-6 and SEQ ID NOs: 7-9, respectively; (L) is a linker; and (M) is a maytansinoid; and wherein the linker (L) links (A) to (M); wherein an increased expression level has been detected in a cancer sample isolated from the patient for at least one gene selected from the group consisting of: SLC6A16, CD79A, BASP1, CXCR5, BIK, LY86, TLR10, CD86, LCK, CD22, PTPN22, BCL6, PIK3IP1, CDKN2A, AFF3, PIM1, MGMT, PDE4B, NFKBIE, SYK, FOXO1, CHI3L2, FAM117B, LPAR5, NFATC1, PTPN22, RBM38, and SGPP1.
An aerosol-generating device for heating an aerosol-forming substrate to generate an aerosol, the aerosol-generating device comprising: a substrate cavity configured to receive an aerosol-forming substrate ; and an electromagnetic field generator configured to generate a radio frequency (RF) electromagnetic field in the substrate cavity, the electromagnetic field generator comprising a solid state RF transistor, wherein the solid state RF transistor comprises a LDMOS transistor, a GaAs FET, a SiC MESFET or a GaN HFET. a substrate cavity configured to receive an aerosol-forming substrate ; and an electromagnetic field generator configured to generate a radio frequency (RF) electromagnetic field in the substrate cavity, the electromagnetic field generator comprising a solid state RF transistor, wherein the solid state RF transistor comprises a LDMOS transistor, a GaAs FET, a SiC MESFET or a GaN HFET.
A concentrator photovoltaic unit configured to guide sunlight concentrated by a primary concentrating portion , to a power generating element by means of a secondary concentrating portion , wherein when upper-lower positional relationship on an optical path is defined such that the primary concentrating portion is at an upper position than the secondary concentrating portion , the secondary concentrating portion includes: a secondary lens provided above the power generating element ; a lens supporting portion configured to support the secondary lens ; a shielding plate being a flat-plate-shaped member preventing sunlight to pass therethrough whereas allowing an upper portion of the secondary lens to be exposed from a hole formed in the flat-plate-shaped member, the shielding plate being fixed in a state of being mounted to the lens supporting portion , the shielding plate being configured to block light converging at a position outside the secondary lens , a covering portion made of translucent resin, the covering portion being configured to cover a surface of the secondary lens ; and a sealing portion made of translucent resin, the sealing portion filling a space of a gap between the power generating element and the secondary lens , in the lens supporting portion , characterized in that the upper end face of the lens supporting portion includes: a lower stage portion at an inner side, the lower stage portion being configured to support the secondary lens at an inner edge of the lower stage portion , and configured to serve as a resin receiving portion receiving a lower end of the covering portion ; and a higher stage portion at an outer side, the higher stage portion being at a higher position than the lower stage portion and being configured to have the shielding plate mounted thereto. a secondary lens provided above the power generating element ; a lens supporting portion configured to support the secondary lens ; a shielding plate being a flat-plate-shaped member preventing sunlight to pass therethrough whereas allowing an upper portion of the secondary lens to be exposed from a hole formed in the flat-plate-shaped member, the shielding plate being fixed in a state of being mounted to the lens supporting portion , the shielding plate being configured to block light converging at a position outside the secondary lens , a lower stage portion at an inner side, the lower stage portion being configured to support the secondary lens at an inner edge of the lower stage portion , and configured to serve as a resin receiving portion receiving a lower end of the covering portion ; and a higher stage portion at an outer side, the higher stage portion being at a higher position than the lower stage portion and being configured to have the shielding plate mounted thereto.
A physiological signal monitoring system comprising: a pendant comprising a system on a chip (SoC) that includes a data store and a processor ; and a flexible patch comprising gold pads to connect with the pendant and a plurality of electrodes (425; 435) configured to harvest physiological signals and in electrical communication with a flexible printed circuit board (PCB); a cradle mounted on the patch , wherein an outer perimeter of the patch extends beyond an entirety of an outer perimeter of the cradle ; wherein the pendant is configured to removably couple with the cradle ; and wherein the processor is configured to receive, from at least one of the plurality of electrodes, electrical signals from a heart of a patient, and to store the electrical signals as electrocardiogram (ECG) data to the data store . a pendant comprising a system on a chip (SoC) that includes a data store and a processor ; and a flexible patch comprising gold pads to connect with the pendant and a plurality of electrodes (425; 435) configured to harvest physiological signals and in electrical communication with a flexible printed circuit board (PCB); a cradle mounted on the patch , wherein an outer perimeter of the patch extends beyond an entirety of an outer perimeter of the cradle ; wherein the pendant is configured to removably couple with the cradle ; and wherein the processor is configured to receive, from at least one of the plurality of electrodes, electrical signals from a heart of a patient, and to store the electrical signals as electrocardiogram (ECG) data to the data store .
An optical module for a head-mounted device that is configured to present content to a user, the optical module comprising: an optical module housing assembly that has a first end and a second end, wherein the optical module housing assembly includes a first portion that is connected to a second portion; a lens that is connected to the optical module housing assembly and is positioned at the first end of the optical module housing assembly, wherein the lens is retained by securing two or more projections of the lens between the first portion of the optical module housing assembly and the second portion of the optical module housing assembly in the direction of the optical axis, wherein the first portion of the optical module housing assembly includes a first peripheral wall portion that extends around the optical axis, the second portion of the optical module housing assembly includes a second peripheral wall portion that extends around the optical axis, and the first peripheral wall portion and the second peripheral wall portion engage the two or more projections to restrain movement of the lens relative to the optical module housing assembly; a display assembly that is connected to the optical module housing assembly and is positioned at the second end of the optical module housing assembly, wherein the display assembly is configured to cause the content to be displayed to the user through the lens; and a camera that is configured to obtain images of the user's eye through the lens, wherein the camera is connected to the optical module housing assembly and is positioned at the second end of the optical module housing assembly. an optical module housing assembly that has a first end and a second end, wherein the optical module housing assembly includes a first portion that is connected to a second portion; a lens that is connected to the optical module housing assembly and is positioned at the first end of the optical module housing assembly, wherein the lens is retained by securing two or more projections of the lens between the first portion of the optical module housing assembly and the second portion of the optical module housing assembly in the direction of the optical axis, wherein the first portion of the optical module housing assembly includes a first peripheral wall portion that extends around the optical axis, the second portion of the optical module housing assembly includes a second peripheral wall portion that extends around the optical axis, and the first peripheral wall portion and the second peripheral wall portion engage the two or more projections to restrain movement of the lens relative to the optical module housing assembly; a display assembly that is connected to the optical module housing assembly and is positioned at the second end of the optical module housing assembly, wherein the display assembly is configured to cause the content to be displayed to the user through the lens; and a camera that is configured to obtain images of the user's eye through the lens, wherein the camera is connected to the optical module housing assembly and is positioned at the second end of the optical module housing assembly.
A roller head for a skin treatment device configured to drive the roller head by an electro-mechanical mechanism; a surface of the roller head comprises at least one peak , the at least one peak is arranged so that, when in use, a first surface of the peak contacts with the skin with when the roller head rotated in a clockwise direction and a second surface of the peak contacts with the skin with when the roller head rotated in an anticlockwise direction wherein the first surface differs from the second surface and the first surface is configured to provide a first benefit and the second surface is configured to provide a second benefit wherein the roller head further comprising an additional surface configured to provide a further benefit when the roller head is rotated clockwise and anticlockwise. a surface of the roller head comprises at least one peak , the at least one peak is arranged so that, when in use, a first surface of the peak contacts with the skin with when the roller head rotated in a clockwise direction and a second surface of the peak contacts with the skin with when the roller head rotated in an anticlockwise direction wherein the first surface differs from the second surface and the first surface is configured to provide a first benefit and the second surface is configured to provide a second benefit wherein the roller head further comprising an additional surface configured to provide a further benefit when the roller head is rotated clockwise and anticlockwise.